« FDA Requests Label Change for All Sleep Disorder Drug Products | Main | Decernis Announces Regulatory Compliance System (PR Web) Decernis releases information »

FDA Approvals - Endo and Vernalis Plc Announce Three-Month Extension of PDUFA Date


Endo and Vernalis Plc Announce Three-Month Extension of PDUFA Date for Frova(R) sNDA (RedNova)
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and Vernalis plc (LSE: VER) (NASDAQ: VNLS) today announced that the U.S.

Helpful friends in high places (The Star-Ledger)
WASHINGTON -- The drug in dustry may be facing tough times in the Democratic-controlled Congress, but it can still count on the backing of the Bush administration.
 

©2006 FDA-News.com. All rights reserved.